IL17A and Atherosclerotic lesion: Furthermore, the administration of rIL-17 to Ldlr−/− mice significantly reduced the development of atherosclerotic lesions and reduced IL-1-induced endothelial VCAM-1 expression in vitro, suggesting that IL-17 inhibits the development of atherosclerosis.